DAVID LAZARBusiness Directories,Company Directories

Company Name: Corporate Name:	DAVID LAZAR
Company Title:	+ EZHomeremedies.com + \| Natures Cures. A Healthy Life.
Company Description:
Keywords to Search:
Company Address:	15757 N 90TH PL APT 2109 - SCOTTSDALE,SCOTTSDALE,AZ,USA
ZIP Code: Postal Code:	85260
Telephone Number:	4806940705 (+1-480-694-0705)
Fax Number:
Website:	ezhomeremedies. com;fineyoungbitches. com;insidethesenate. com;lowestpossiblerates. com;repealtheincomet
Email:
USA SIC Code(Standard Industrial Classification Code):	5211
USA SIC Description:	Building materials
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
MCGUIGAN BEVERLEY
LANDNET SYSTEMS; INC.
JAPANTRAVELBOOKSCOM

Next company profile:
SCOTTSDALE CONVENTION BUREAU
DESERT MOUNTAIN ASSOCIATES
SEMLOW; RICHARD

Company News:

David Lazar (author) - Wikipedia
David Lazar (author) David Lazar (born January 28, 1957) is an American writer and editor, primarily known as an essayist
Investor pumps $3M into Cyclacel in return for CEO role
Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as well as taking on the top role and shaking up the board
KALA BIO Secures $6 Million Investment and Appoints David E. Lazar. . .
KALA BIO announces a $6 million securities purchase agreement and new leadership under David E Lazar, setting the stage for potential redevelopment of its product pipeline and a search for strategic alternatives following clinical setbacks Key details of the transaction and future outlook are highlighted
Kala Surges on Lazars $6M Investment, Appointment as CEO
Kala Bio shares surged after the biopharmaceutical company said it had named David Lazar as chief executive and board chair, following the investor's purchase of $6 million in stock Kala shares
KALA BIO Enters Into $6 Million Securities Purchase Agreement with . . .
In conjunction with the securities purchase agreement's first closing, KALA has issued new shares of non-voting convertible Series AA preferred stock in exchange for Mr Lazar's initial investment
KALA BIO enters $6M investment deal with David Lazar, new CEO | KALA . . .
KALA BIO secures a $6M securities purchase agreement, receiving $1 8M at first closing, as new CEO David Lazar leads product review and strategic options
KALA BIO, Inc. Announces $6 Million Securities Purchase Agreement and . . .
KALA BIO, Inc , a clinical-stage biopharmaceutical company focused on innovative therapies for eye diseases, has entered a $6 million securities purchase agreement with private investor David E Lazar, who has been appointed as the new CEO and Chairman of the Board The company received $1 8 million in an initial closing under this agreement
KALA BIO Enters Into $6 Million Securities Purchase . . . - BioSpace
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E Lazar December 2, 2025 | 5 min read
David Lazar - David Lazar
Six of his essays have been “Notable Essays of the Year” according to Best American Essays He created the undergraduate and Ph D programs in Nonfiction Writing at Ohio University, and directed the creation of the undergraduate and M F A programs in Nonfiction Writing at Columbia College Chicago
David Lazar: Photographer
David Lazar Galleries Bio Book Shop Luminous Journeys Photo Tours Prints Blog Contact